Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Synthetic Biologics Inc. (SYN)

0.5225   -0.002 (-0.29%) 02-14 15:58
Open: 0.53 Pre. Close: 0.524
High: 0.5321 Low: 0.5049
Volume: 193,383 Market Cap: 9M
Synthetic Biologics Inc is a late-stage biotechnology company focused on developing gut microbiome therapeutics. It is also developing monoclonal antibody therapies for the treatment of pertussis.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.53 - 0.534 0.534 - 0.537
Low: 0.493 - 0.497 0.497 - 0.5
Close: 0.515 - 0.521 0.521 - 0.526

Technical analysis

as of: 2020-02-14 4:32:55 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.67     One year: 0.74
Support: Support1: 0.48    Support2: 0.40
Resistance: Resistance1: 0.57    Resistance2: 0.63
Pivot: 0.54
Moving Average: MA(5): 0.53     MA(20): 0.54
MA(100): 0.46     MA(250): 0.52
MACD: MACD(12,26): 0.01     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 15.77     %D(3): 21.00
RSI: RSI(14): 48.07
52-week: High: 0.85  Low: 0.37  Change(%): -19.6
Average Vol(K): 3-Month: 22228  10-Days: 24179

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
SYN has closed above bottom band by 28.5%. Bollinger Bands are 12% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Smoking Gun? Chinese Scientist Finds "Killer Coronavirus Probably Originated From A Laboratory In Wuhan"
Smoking Gun? Chinese Scientist Finds "Killer Coronavirus Probably Originated From A Laboratory In Wuhan" The uncertainty and the debate over the origins of the coronavirus pandemic are growing with each passing day. One week after the White House asked scientists to finally investigate whether the Covid-19 virus was bio-engineered (i.e., created in a lab), none other than CNBC jumped on the bandwagon and echoing a similar question by Senator Tom Cotton - and of course, Zero Hedge - said " maybe the coronavirus was man made." All this is taking place as the mainstream press presses on with the popular theory that the virus emerged from the Huanan seafood market in Wuhan (we recently showed why this appears very unlikely) while branding anyone who suggests that the coronavirus might have originated as a bioweapon developed in a secretive Wuhan lab as deranged conspiracy theorist (a propaganda approach first popularized in the 1960s by the CIA to discredit controversial views ). Indeed, just today, the FT reported that Trevor Bedford, of the Fred Hutchinson Cancer Research Center in Seattle, "rubbished stories circulating on social media that Covid-19 was created at Wuhan Institute of Virology or elsewhere in China." Bedford is of course entitled to his opinion, which was only reinforced by the lack of any dissenting views from the scientific community, especially in "ground zero", China.

Synthetic Biologics to Report 2019 Year End Operational Highlights and Financial Results on February 20, 2020
ROCKVILLE, Md., Feb. 13, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, intends to report…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 16.81
Shares Float (M) 16.30
% Held by Insiders 0.09
% Held by Institutions 12.87
Shares Short (K) 51
Shares Short P. Month (K)

Stock Financials

EPS -1.783
Book Value (p.s.) 0.010
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -62.3
Return on Equity (ttm) -146.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.920
Qtrly Earnings Growth
Operating Cash Flow (M) -13.56
Levered Free Cash Flow (M) -7.96

Stock Valuations

P/E -0.29
P/E Growth Ratio
P/BV 52.24
P/CF -0.65

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-08-12
Last Split Ratio 0.029
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.